Impact of Microbiota Diversity on Inflammatory Bowel Disease
Open Access
- 21 March 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (4) , 710
Abstract
Inflammatory bowel disease (IBD) is a chronic condition that includes two main types, Crohn’s disease (CD) and ulcerative colitis (UC), involving inflammation of the gastrointestinal (GI) tract. The exact cause of IBD is unknown but could be a combination of genetic, environmental, and immune system factors. This study investigated the impact of IBD on microbiota diversity by evaluating the differences in microbial composition and the microbiota of a control group (A) of healthy individuals and a group (B) of IBD patients. Sixty biopsies were collected from participants recruited from hospitals in Makkah, Saudi Arabia. Biopsy specimens were taken during colonoscopy examination, and bacterial identification was performed by extracting ribosomal DNA from sigmoid colon biopsies using a DNeasy Blood & Tissue Kit. Metagenomics and bioinformatics analyses were then conducted to analyze and compare the microbiota in the two groups. The results showed that the varieties of core microbiome species were 3.81% greater in the IBD patients than in the members of the control group. Furthermore, the differences between the groups were significantly greater than the variations within each group. Differences between the two groups were detected in the relative abundance of Clostridium nexile, Ruminococcus gnavus, Ruminococcus faecis, and Escherichia coli. These results indicate that microbiota could play a role in the pathogenesis of IBD and suggest that microbial diversity can serve as a biomarker for diagnosing the disease and monitoring its progression.Keywords
This publication has 64 references indexed in Scilit:
- Gut Microbiota as an Endocrine Organ: Unveiling Its Role in Human Physiology and HealthApplied Sciences, 2024
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 2021
- Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and ManagementGastroenterology, 2021
- Inflammatory Bowel Disease–Associated Changes in the Gut: Focus on Kazan PatientsInflammatory Bowel Diseases, 2020
- Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiotaAnaerobe, 2018
- Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel diseaseGut, 2016
- Enhanced butyrate formation by cross-feeding betweenFaecalibacterium prausnitziiandBifidobacterium adolescentisFEMS Microbiology Letters, 2015
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseCell Host & Microbe, 2014
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007